Gilead Sciences, Inc. (Nasdaq:GILD) announced today the promotion
of Jim Meyers to Senior Vice President, Commercial Operations, North
America. Mr. Meyers is responsible for the company's commercial
organization in North America, including U.S. and Canadian sales,
marketing and commercial operations, reporting to Kevin Young,
Gilead's Executive Vice President, Commercial Operations. In this new
role, Mr. Meyers will join Gilead's Executive Committee.
Mr. Meyers joined Gilead in 1996 as a regional sales director and
relocated to the company's headquarters in 1997 to head the HIV
marketing team. In 2001 he was named Senior Director of U.S. Sales,
overseeing the expansion of the company's field sales organization in
advance of the launch of Gilead's first product for the treatment of
HIV. He was promoted to Vice President in 2002, and appointed to the
position of Vice President of the U.S. Commercial organization in
2004. Prior to joining Gilead, Mr. Meyers held positions of increasing
responsibility in sales, training, marketing and management with
Zeneca Pharmaceuticals and Astra USA. He is a graduate of Boston
College, with a Bachelor's degree in economics.
"Over the last ten years, Jim has contributed significantly to the
growth and success of Gilead's commercial organization," said Mr.
Young. "As we extend our commercial presence and expand into new
therapeutic areas, Jim's leadership and depth of expertise will ensure
we continue to meet our aggressive goals and deliver new medications
to those patients most in need."
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of unmet
medical need. The company's mission is to advance the care of patients
suffering from life-threatening diseases worldwide. Headquartered in
Foster City, California, Gilead has operations in North America,
Europe and Australia.
For more information on Gilead, please call the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235) or visit
www.gilead.com.
